
Grant Proposal Assistant
This walks you through writing NIH, NSF, and foundation grant proposals by forcing you to answer the four questions reviewers actually care about: testable hypothesis, why now, what's genuinely new, and can you actually do it. The workflow is structured around an eight-step checklist covering everything from specific aims to compliance, with section-by-section frameworks that show exactly what goes in significance versus innovation versus approach. It includes a specific aims template, reviewer mindset guidance, and an evaluation rubric requiring a minimum 3.5 average score. Use it when drafting R01s, revising after getting triaged, or reality-checking whether your "innovative approach" statement actually says anything specific.
- skills.sh installs
- 353
- GitHub stars
- 193
- last updated
- Aug 21, 2026
Install
$ npx -y skills add lyndonkl/claude --skill grant-proposal-assistant --agent claude-codeInstalls into .claude/skills of the current project.
Files
Grant Proposal Assistant
Table of Contents
Related skills (not this one):
- Manuscripts:
scientific-manuscript-review - Fellowship personal statements:
career-document-architect - Letters of recommendation:
academic-letter-architect
Core Questions
Every grant proposal must convincingly answer these four questions:
1. What is the central hypothesis?
- Testable, specific, falsifiable
- Not just "we will study X" but "we hypothesize that X causes Y through mechanism Z"
2. Why is the problem important NOW?
- What gap exists in current knowledge?
- Why is this gap significant for the field/patients/society?
- Why is this the right time (new tools, preliminary data, shifting paradigm)?
3. What makes the approach innovative?
- What is genuinely new (concept, method, application)?
- How does this advance beyond incremental improvement?
- Innovation in approach AND/OR innovation in what will be learned
Sponsors
Details
- Repository
- github.com/lyndonkl/claude
- Categories
- Git & Pull Requests, Documentation, Code Review & Quality, Data Science & ML
- First seen
- Jun 3, 2026